PROSAPIENT LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +16.8%

  £28,289,617 → £33,051,989

• Cash

  -19.9%

  £3,232,814 → £2,589,968

• Net assets

  -9%

  £6,355,050 → £5,784,072

• Employees

  +4.6%

  217 → 227

  highest in 5 filed years

• Operating profit

  +91.6%

  -£4,036,603 → -£338,983

• Profit before tax

  +85.9%

  -£4,108,102 → -£580,852

• Wages

  +0.4%

  £13,074,745 → £13,125,116

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Moore Kingston Smith LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Group structure

1. PROSAPIENT LIMITED · parent
   1. Prosapient Inc 100% · United States · Market research and public opinion pooling
   2. Prosapient Canada Inc 100% · Canada · Market research and public opinion pooling
   3. Prosapient Portugal 100% · Portugal · Market research and public opinion pooling

Significant events

• “On 2 May 2025, Prosapient Limited (the Company) entered into an invoice discounting agreement with RBS Invoice Finance Limited. On the same day, the Company repaid in full the non-convertible loan notes which it had issued in November 2023. The principal repayment amount for the loan notes was £1,500,000.”
• “The Company has entered into a new lease agreement for a property located in Toronto, Canada, effective from 1 September 2025. The lease was formally signed on 28 April 2025. The lease term is for a period of five years with an annual rental commitment of CAD$358,590 (GBP£195,000).”
• “The Company has also entered into a new lease agreement for a property located in Lisbon, Portugal, effective from 1 October 2025. The lease was formally signed on 1 August 2025. The lease term is for a period of five years with an annual rental commitment of EUR€244,100 (GBP£212,000).”
• “On 7 February 2025, the company issued 1000 A ordinary shares each having a nominal value of £0.00001 and were issued for consideration of £10 each.”
• “On 18 February 2025, the company issued 400 A ordinary shares each having a nominal value of £0.00001 and were issued and for consideration of £10 each.”
• “On 18 February 2025, the company issued 100 A ordinary shares each having a nominal value of £0.00001 and were issued for consideration of £24 each.”
• “On 11 July 2025, the company issued 300 A ordinary shares each having a nominal value of £0.00001 and were issued for consideration of £10 each.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

12

last 12 months

Capital events

10

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.